Origin.bio
Latest round
- Seed
Last raised
- Apr 2021
Total raised
- $15M
Investors
- 4
About Origin.bio
bio GmbH specializes in biotechnology solutions that utilize artificial intelligence for biological research. The founder's history includes previous ventures in the biotechnology sector, although specific details are not provided.bio specializes in advanced biotechnology solutions that harness artificial intelligence to streamline biological research and applications. Their core offerings include data-driven platforms for analyzing and interpreting biological data, catering to sectors like pharmaceuticals, agriculture, and environmental science, addressing challenges of data complexity and the demand for accelerated insights.bio primarily stems from business-to-business (B2B) transactions, where clients subscribe to their software platforms or partner to access their AI tools. The company employs a tiered subscription model to accommodate various organizational needs, ensuring steady revenue from both long-term subscriptions and one-time fees for specific projects. This includes the development and launch of new products aimed at enhancing their platform’s capabilities and expansion into additional geographic markets, though specific regions or product release dates have not been disclosed.
Who invested in Origin.bio
4 investors across 1 round
See all investors in Origin.bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 28, 2021
Amount
$15M
Investors
Questions about Origin.bio
Who invested in Origin.bio?
Origin.bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Origin.bio raised?
Origin.bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Origin.bio last raise money?
Origin.bio's most recent round on record is a Seed, in Apr 2021.
What does Origin.bio do?
bio GmbH specializes in biotechnology solutions that utilize artificial intelligence for biological research.
Where is Origin.bio headquartered?
Origin.bio is headquartered in Germany.
Which VCs invest in companies like Origin.bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Origin.bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Origin.bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.